Navigation Links
Sphere Fluidics: Expanding Executive Team for Growth of New Market Opportunity

CAMBRIDGE, England, December 10, 2013 /PRNewswire/ --

Sphere Fluidics Limited has developed unique technology for single cell analysis and characterization and provides proprietary products and novel services for this rapidly-growing market. This enabling approach can find rare variants in large cell populations and Sphere Fluidics has patented novel Cyto-Mine™ technology that permits up to one billion assays per biochip per day. Their technology provides significant operational benefits for biopharmaceutical discovery and development, cancer variation studies, analysis of antibiotic-resistance mutants and identification of novel enzymes and synthetic biology pathways. Sphere Fluidics completed a funding round of circa $3 million earlier this year and has now moved into a larger facility nearby to Cambridge (UK) to enable growth.


The firm has used the funding to recruit new technical staff, a Commercial Director and has now hired a new R&D Director (Dr Marian Rehak). Dr Rehak previously held Senior R&D positions with Unipath and DxTech, has more than 20 years in Life Sciences R&D and has been hired to help grow the business. "I am excited to be joining the Sphere Fluidics team at this crucial time. We will now not only provide enabling R&D Services, but also develop and launch new Products (e.g. novel instrumentation systems) for single cell analysis," says Dr. Rehak. "Our systems will not only enabling for discovery and development of diverse biopharmaceuticals, but has also created excitement in the emerging field of synthetic biology," he states.

Sphere Fluidics now has almost 120 different, international organizations buying their products. These include leading pharmaceutical companies, Life Sciences biotechsa nd well-known research institutions. The Company has also recently signed several, new collaborative R&D agreements with a number of Blue Chip pharmaceutical companies in an acceleration of their Service business.

"The Company has recently completed comprehensive, market analysis to ensure that our new instrumentation systems were defined by the customer base and are targeted into major global markets," says Dr Frank F. Craig (CEO). "Dr Rehak is part of our plan to rapidly grow the R&D function and our select markets. We welcome him into the Company and look forward to his contribution to our continued success."

Press Contact
Sphere Fluidics Limited.
Contact Dr Frank F. Craig on:
Tel: +44(0)1223-804201

SOURCE Sphere Fluidics Limited
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CryoLife Completes Acquisition of Hemosphere
2. PhytoSPHERE Systems, a Medical Marijuana Inc Portfolio Company, to Bring Production Facilities to Europe through Canipa Holdings.
3. Medical Marijuana Inc.s Subsidiary, PhytoSPHERE Systems, Signs the Largest Production Contract in Company History Valued at $7.5 Million
4. Presentation of Possible "Fountain of Youth" Pill Creating "Celebrity" Atmosphere at San Antonio Scientific Conference
5. Medical Marijuana, Inc. Portfolio Company PhytoSPHERE Systems, LLC Cites Broad Applications of its 2013 Harvest of Uniquely Valuable Hemp Oil
6. Sphere Fluidics Successfully Closes a $2.5 million Series A Investment Round
7. Life Technologies Partners with Ridom and Releases SeqSphere+ Software to Speed and Simplify Bacterial Typing
8. PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
9. Sphere Fluidics: Ramping up Growth to Find the "One in a Billion"!
10. Sphere Fluidics: beschleunigtes Wachstum, um die Ausnahme zu finden!
11. MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer
Post Your Comments:
(Date:11/24/2015)... , November 25, 2015 The ... to repeated failure of IVF cycles. After failure of ... dejected and had lost all hopes that she would be able to ... miracle child conceived after failure of over 15 IVF ... (UK) before they decided to take one last attempt with Gaudium ...
(Date:11/24/2015)... CARLOS, Calif. , Nov. 24, 2015 ... a leader in non-invasive genetic testing and ... announced that it will present at the ... in New York on Wednesday, December 2, 2015 at 1:00 p.m. ET.  Matthew ... the Company,s financial results, business activities and ...
(Date:11/24/2015)... TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ - ... NASDAQ: EPIX ) announced today that the first ... study of EPI-506 as a treatment for metastatic castration-resistant ... and Canada.  --> ... --> In the Phase 1/2 clinical trial, ESSA ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... Today, Mothers Against Drunk ... roadways has dropped below 10,000 for the first time since 2011. In 2014, there ... According to data released by the National Highway Traffic Safety Administration (NHTSA), 32,675 people ...
(Date:11/25/2015)... ... ... An unlikely combination of recycled plastic shopping bags in ... to have a more dignified and comfortable night’s sleep. , Residents of Friendship ... bags into sleeping mats for the homeless. The project, according to Jeannette ...
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... bunion treatment, is offering lower prices in an early celebration of the early ... the promotional price of $29.95 each (normally $33.95 ea). Black Friday promotional pricing ...
(Date:11/24/2015)... ... November 24, 2015 , ... Young patients with a wide variety ... Wolfman and Dr. Kedar S. Lele, who are pediatric dentists in Tucson, AZ ... the WaterLase iPlus 2.0™ system causes minimal discomfort and bleeding to the patient during ...
(Date:11/24/2015)... ... , ... DMG Productions announced that they will feature Aphria, Inc., in an ... Channel. Dates and show times TBA. , Aphria, Inc., is a publicly traded company ... and supplying medical marijuana pursuant to the Marijuana for Medical Purposes Regulations (the “MMPR”). ...
Breaking Medicine News(10 mins):